• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Advances in Studies on Enzyme Inhibitors as Drugs: Volume 2: Miscellaneous Drugs

Advances in Studies on Enzyme Inhibitors as Drugs: Volume 2: Miscellaneous Drugs

9781536105056
1 385,94 zł
1 247,34 zł Zniżka 138,60 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 1 247,34 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
This book which is edited by eminent scientist Satya P. Gupta, covers the most recent development on design and discovery of the most useful drugs acting against several life threatening diseases such as cancer, viral infections and many others in two volumes. All of these drugs are based on inhibitions of various enzymes. Most human diseases are found to be associated with the overexpression of the enzymes. The book presents the structural aspects of various enzymes, their active sites, and the structural requirements of chemicals for strong interactions with enzymes. Volume One contains twelve chapters related to enzyme inhibitors acting as anticancer and antiviral drugs (each written by highly acclaimed authors), and Volume Two contains ten chapters on enzyme inhibitors acting against miscellaneous diseases written by equally competent authors. The book may be an asset for drug industries, research organisations, and individual researchers.
Szczegóły produktu
72327
9781536105056
9781536105056

Opis

Rok wydania
2017
Numer wydania
1
Oprawa
twarda
Liczba stron
330
Wymiary (mm)
180.00 x 260.00
Waga (g)
762
  • Preface; Protease Inhibitors as Potential Antimalarial Agents; Enzymatic Targets for Drug Discovery Against Alzheimers Disease; Design & Development of Some Selective Enzyme Inhibitors for Parkinsons & Alzheimers Diseases Based on Molecular Modeling & Dynamics Studies; Pyruvate Dehydrogenase Kinases (PDHKs) & Their Inhibition: A Possible Line of Treatment for Diabetes, Heart Ischemia & Cancer; Advances in Studies on COX/LOX Enzymes Inhibitors as Drugs; Design & Development of Matrix Metalloproteinase Inhibitors Containing Zinc-Binding Groups, without Zinc-Binding Groups, & Mechanism-Based; Computational Study of D-Amino Acid Oxidase & Its Inhibitors; Cytochrome P450 Inhibitors Used as Drugs; Quantum Chemical Insights into Metabolic Inhibition of Cytochrome P450 Enzymes: Piperine, Curcumin, & Metal Complexes of Curcumin: Promises & Bioavailability; Design & Development of Angiotensin-Converting Enzyme Inhibitors; Index.
Komentarze (0)